Activation of anti-hepatitis C virus responses via Toll-like receptor 7.
about
HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1Toll-Like Receptors in the Pathogenesis of Autoimmune DiseasesInnate Immunity and Immune Evasion by Enterovirus 71RNA mediated Toll-like receptor stimulation in health and diseaseInnate immune responses in hepatitis C virus infectionInvestigating Toll-Like Receptor Agonists for Potential To Treat Hepatitis C Virus InfectionPlasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patientsHepatitis C Virus Is a Weak Inducer of Interferon Alpha in Plasmacytoid Dendritic Cells in Comparison with Influenza and Human Herpesvirus Type-1Pharmacokinetic-Pharmacodynamic Modeling of Alpha Interferon Response Induced by a Toll-Like 7 Receptor Agonist in MiceTreatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune systemInduction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 DiabetesVirus-related liver cirrhosis: molecular basis and therapeutic options.Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.Poly-thymidine oligonucleotides mediate activation of murine glial cells primarily through TLR7, not TLR8.Induction and evasion of innate antiviral responses by hepatitis C virus.Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates.Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response.Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2.IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and diseaseResiquimod and other immune response modifiers as vaccine adjuvants.Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus.Coinfection with HIV-1 and HCV--a one-two punch.Structural requirements for TLR7-selective signaling by 9-(4-piperidinylalkyl)-8-oxoadenine derivatives.Synthesis and Evaluation of Conjugates of Novel TLR7 Inert Ligands as Self-Adjuvanting Immunopotentiators.Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand.Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists.Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis.Protective role of Toll-like Receptor 3-induced type I interferon in murine coronavirus infection of macrophages.Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients.Upping the antedrug: is a novel anti-inflammatory Toll-like receptor 7 agonist also a bronchodilator?Impaired toll-like receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virus.Current and emerging antiviral treatments for hepatitis C infectionMast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response.Interaction of hepatitis C virus with the type I interferon system.Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells.Identification of substituted pyrimido[5,4-b]indoles as selective Toll-like receptor 4 ligandsObstacles to effective Toll-like receptor agonist therapy for hematologic malignancies.Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study
P2860
Q24339505-F36C1A23-1931-400E-8F59-1C387987384DQ26770257-67B704D3-E281-4F1F-BDAE-6DD4212C4AA8Q26773329-FACDCCF1-FE74-4EC8-8DED-037CD73FD3F9Q26999252-F41E411D-40B6-425E-802B-05DB0C3CCA28Q27023055-C0C5A048-4FCD-423F-A8BA-AA28748A4A3EQ27480922-7251AAEE-6B31-4328-9F76-6FE47E474CECQ27482532-D96EDE43-9A76-4EA9-B773-EBCC24BFAB99Q27487765-039F941D-E9A8-4D74-8D15-5F308A33D4D9Q27490955-79838481-7DC9-47B2-A862-49909AAA7961Q28484146-1FDEA1EF-2D61-427D-9BF3-A923A46CAC4CQ28548359-D81A4FFF-A320-40BE-9A40-92E8D519363DQ33718267-DB34CACE-02D8-4C0A-A821-9A195D1E69D8Q33812840-5C2BF581-2852-4A4F-BE28-F906FCF2763CQ33979985-A2751495-34F8-41BE-8D92-02C581A9067BQ34003764-D9424CB3-8700-43B7-AA17-839C37F33CA5Q34291783-6349B417-2086-41EF-BE83-A0AB9331B373Q34485161-EE40FEC3-6FDB-4F47-B08A-7FE330F8B8BBQ34672618-2404F162-5738-408B-9DB8-4892C0258477Q34697945-7E43CA7F-D6F6-4F10-89A1-8F9B4883F285Q34700325-BA5BFB91-509E-4241-AE0D-C88C99ED8D8EQ34833960-C7208737-8949-4DB9-9034-295A27CD0BAFQ35137038-4B71ECC7-B1CA-4011-906E-09638EBE3A03Q35170105-830F8A97-2FCD-481A-AFFD-C1F797DF5E23Q35178898-E083A657-EBC6-4656-B2A5-D316F5DA54CAQ35676749-8DD970C9-00D3-41B8-AC81-54FF07A313E5Q35981265-8106C042-A94D-490A-98FF-A5778BFB3A3FQ36004897-F23F1341-94EA-4EF9-BA73-974FB00B7813Q36067731-F34C5994-F64B-4E8C-8AB6-7E6219511837Q36085542-7DBCFF92-F2E7-4E0C-895E-0D1CC3B1A964Q36159164-62CF147E-7301-4C8D-828B-DDA7263AFB33Q36606736-F44AD202-579A-49E6-B611-E035332583E5Q36729900-04798A0A-23EE-4AED-A898-6EAC8F4A1B5DQ36808165-927F4A72-75F4-4531-BB4A-E10F7C8C00FCQ36898663-C94FBF95-D901-48EF-BA5C-70F4CA173646Q36935522-543D6B65-1C2C-4369-8D5C-35A7A4AD342CQ36937316-6B37F0AC-065F-4215-BCF9-D756CB0E64CBQ37043647-320A726D-6D1F-41B0-A590-A2624BEDE594Q37051022-DB078189-0098-4A09-93EE-99C41B64232CQ37081321-C634A317-ECA5-4B09-8EE8-F9ED42D76A82Q37180038-06498E19-3D27-4C04-AAFA-D9EE551C8631
P2860
Activation of anti-hepatitis C virus responses via Toll-like receptor 7.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Activation of anti-hepatitis C virus responses via Toll-like receptor 7
@nl
Activation of anti-hepatitis C virus responses via Toll-like receptor 7.
@ast
Activation of anti-hepatitis C virus responses via Toll-like receptor 7.
@en
type
label
Activation of anti-hepatitis C virus responses via Toll-like receptor 7
@nl
Activation of anti-hepatitis C virus responses via Toll-like receptor 7.
@ast
Activation of anti-hepatitis C virus responses via Toll-like receptor 7.
@en
prefLabel
Activation of anti-hepatitis C virus responses via Toll-like receptor 7
@nl
Activation of anti-hepatitis C virus responses via Toll-like receptor 7.
@ast
Activation of anti-hepatitis C virus responses via Toll-like receptor 7.
@en
P2093
P2860
P3181
P356
P1476
Activation of anti-hepatitis C virus responses via Toll-like receptor 7.
@en
P2093
Carol Shen
Christina C N Wu
Dennis A Carson
Howard B Cottam
Jongdae Lee
Ki Jeong Lee
Kyoko Katakura
Michael Chan
Michelle Chung
P2860
P304
P3181
P356
10.1073/PNAS.0510801103
P407
P577
2006-01-30T00:00:00Z